StreetInsider.com News Articles

Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half

Fri, 28 Aug 2026 02:48:00 -0400

SAN FRANCISCO, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced late-breaking one-year results from an independent randomized clinical trial proving the Heartflow FFRCT Analysis safely and significantly reduced unnecessary invasive heart procedures by 44% (p < 0.001).

Presented as Late-Breaking Science at the European Society of Cardiology (ESC) Congress 2026, FUSION trial, funded by the Dutch National Health Care Institute, demonstrates that standard coronary computed tomography angiography (CCTA) alone drives overutilization of invasive catheterizations.1 By adding Heartflow FFRCT Analysis to

Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half

Fri, 28 Aug 2026 02:48:00 -0400

Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half

Fri, 28 Aug 2026 02:48:00 -0400

Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half

Fri, 28 Aug 2026 02:48:00 -0400

Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half

Fri, 28 Aug 2026 02:48:00 -0400

Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half

Fri, 28 Aug 2026 02:48:00 -0400

Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half

Fri, 28 Aug 2026 02:48:00 -0400

Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half

Fri, 28 Aug 2026 02:48:00 -0400

Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference

Thu, 27 Aug 2026 16:01:00 -0400

SAN FRANCISCO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the upcoming Wells Fargo 21^st Annual Healthcare Conference. The fireside chat, which will include a slideshow presentation followed by a question-and-answer session, will take place in Boston on Wednesday, September 9, 2026, at 3:45 p.m. ET / 12:45 p.m. PT.

A live and archived version of the fireside chat will be available on the Investor Relations section

Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference

Thu, 27 Aug 2026 16:01:00 -0400

A live and archived version of the fireside chat will be available on the Investor Relations section

Form 4 Heartflow, Inc. For: Aug 21 Filed by: Farquhar John C.M.

Tue, 25 Aug 2026 17:32:00 -0400

si-local-file:///var/storage/secattach/20260825/26975847.html

Form 4 Heartflow, Inc. For: Aug 21 Filed by: Farquhar John C.M.

Tue, 25 Aug 2026 17:32:00 -0400

si-local-file:///var/storage/secattach/20260825/26975847.html

Form 144 Heartflow, Inc. Filed by: Farquhar John C.M.

Fri, 21 Aug 2026 13:07:00 -0400

si-local-file:///var/storage/secattach/20260821/26960470.html

Form 144 Heartflow, Inc. Filed by: Farquhar John C.M.

Fri, 21 Aug 2026 13:07:00 -0400

si-local-file:///var/storage/secattach/20260821/26960470.html

Form 4 Heartflow, Inc. For: Aug 18 Filed by: Farquhar John C.M.

Thu, 20 Aug 2026 17:56:00 -0400

si-local-file:///var/storage/secattach/20260820/26957328.html

Form 4 Heartflow, Inc. For: Aug 18 Filed by: Farquhar John C.M.

Thu, 20 Aug 2026 17:56:00 -0400

si-local-file:///var/storage/secattach/20260820/26957328.html

Form 4 Heartflow, Inc. For: Aug 17 Filed by: Rogers Campbell

Wed, 19 Aug 2026 21:05:00 -0400

si-local-file:///var/storage/secattach/20260819/26951672.html

Form 4 Heartflow, Inc. For: Aug 17 Filed by: Rogers Campbell

Wed, 19 Aug 2026 21:05:00 -0400

si-local-file:///var/storage/secattach/20260819/26951672.html

Form 4 Heartflow, Inc. For: Aug 14 Filed by: Farquhar John C.M.

Tue, 18 Aug 2026 18:39:00 -0400

si-local-file:///var/storage/secattach/20260818/26945834.html

Form 4 Heartflow, Inc. For: Aug 14 Filed by: Farquhar John C.M.

Tue, 18 Aug 2026 18:39:00 -0400

si-local-file:///var/storage/secattach/20260818/26945834.html

Form 144 Heartflow, Inc. Filed by: Farquhar John C.M.

Tue, 18 Aug 2026 17:11:00 -0400

si-local-file:///var/storage/secattach/20260818/26945390.html

Form 144 Heartflow, Inc. Filed by: Farquhar John C.M.

Tue, 18 Aug 2026 17:11:00 -0400

si-local-file:///var/storage/secattach/20260818/26945390.html

Form 144 Heartflow, Inc. Filed by: Rogers Campbell

Mon, 17 Aug 2026 12:52:00 -0400

si-local-file:///var/storage/secattach/20260817/26937060.html

Form 144 Heartflow, Inc. Filed by: Rogers Campbell

Mon, 17 Aug 2026 12:52:00 -0400

si-local-file:///var/storage/secattach/20260817/26937060.html

HeartFlow (HTFL) PT Raised to $40 at Morgan Stanley

Mon, 17 Aug 2026 08:58:25 -0400

Morgan Stanley analyst Patrick Wood raised the price target on HeartFlow (NASDAQ: HTFL) to $40.00 (from $35.00) while maintaining a Equalweight rating.